Denali Therapeutics Inc. DNLI Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $406.4M+0.2% | $418.78M+5.6% | $420.66M+4.0% | $416.95M+5.3% | $405.65M+0.9% | ||
| $140.72M+28.4% | $136.56M+29.5% | $127.16M+27.0% | $116.63M+16.0% | $109.56M+8.0% | ||
| $547.12M+6.2% | $555.34M+10.7% | $547.82M+8.6% | $533.58M+7.5% | $515.21M+2.3% | ||
| -$547.12M-6.2% | -$555.34M-14.0% | -$547.82M-11.8% | -$533.58M-11.0% | -$515.21M-166% | ||
| -$508.02M-11.9% | -$512.54M-21.2% | -$498.74M-16.7% | -$479.03M-14.1% | -$453.94M-231% | ||
| -$2.88-7.5% | -$2.97-15.1% | -$2.92-5.4% | -$2.81+1.7% | -$2.68-176% | ||
| -$535.42M-5.6% | -$544.16M-13.5% | -$537.65M-11.6% | -$524.52M-11.1% | -$507.25M-175% | ||
| -$547.12M-6.2% | -$555.34M-14.0% | -$547.82M-11.8% | -$533.58M-11.0% | -$515.21M-166% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Denali Therapeutics Inc.'s income statement data come from?
- Every line is extracted from Denali Therapeutics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.